Ibalizumab, CAS 680188-33-4

Product Description: Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Anthony Markham. Ibalizumab: First Global Approval. Drugs. 2018 May;78(7):781-785.

CAS Number: 680188-33-4

Molecular Weight: N/A

Compound Purity: 99.52

Research Area: Infection

Solubility: H2O

Target: HIV

• SKU: MEXHY-P99028-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99028-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK